Send Inquiry

Request To Call Back

Edaravone Injection

Get a Price/Quote

MOQ : 1000 Boxes

Edaravone Injection Specification

Indication
Amyotrophic lateral sclerosis (ALS)

Salt Composition
Edaravone 1.5 mg/ml

Dosage Form
Injection

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
1 Vial

Drug Type
General Medicines

Ingredients
Edaravone

Physical Form
Liquid

Function
Neuroprotective agent

Recommended For
Treatment of amyotrophic lateral sclerosis (ALS)

Dosage
As directed by the physician

Dosage Guidelines
Intravenous use only, follow medical advice

Suitable For
Adults

Quantity
20 ml

Edaravone Injection Trade Information

Minimum Order Quantity
1000 Boxes

FOB Port
Mundra Port

Supply Ability
100000 Boxes Per Month

Delivery Time
30 Days

Sample Policy
Within a certain price range free samples are available

Main Domestic Market
All India

Certifications
ISO, WHO, GMP

About Edaravone Injection

Product Description

Product Details:

Injectable Form	Solution
Packaging Size	1*1
Dose	5ml-10ml

We Rewine Pharmaceutical are a leading Manufacturer and Exporter of Edaravone injection in different strength and packing. Our manufacturing facility is certified with WHO-GMP.

We are one of the leading manufacturer and supplier of Edaravone injection.
We have emerged as a reputed manufacturer and supplier of Edaravone injection . This product is tested on several parameters for dispatching an effective range. Offered product is processed with supreme class ingredients and latest processing methodology under the direction of skilled pharmacists. This product is appreciated among our clientele owing to its effectiveness.

Features:

Correctly formulated

Purity

Moisture proof packing

Composition :

Edaravone 10 Ml

Specification:

Product Type : Finished Product

Dose/Strength (ex. 1 mg or 1 ml): 10 ml

Type : ampule

size : 1*10

Usage: Clinical, Hospital

We manufacture and export our brand. We also offer private labelling, Contract manufacturing service.

Efficient Neuroprotection for ALS

Edaravone Injection delivers targeted neuroprotective action to slow the progression of amyotrophic lateral sclerosis (ALS) in adult patients. Its allopathic formulation offers reliable efficacy and safety when administered intravenously under medical guidance. The products clarity and purity further ensure therapeutic value for ALS management.

Quality Packaging and Storage Assurance

Each vial of Edaravone Injection is securely packed in high-quality glass to safeguard the medicine. The shelf life extends up to 24 months when stored in a cool setting, ensuring optimal potency throughout its lifespan. Stringent packaging standards uphold product integrity from manufacturer to end-user.

Precision Formulation and Usage Guidance

Edaravone Injection contains edaravone at 1.5 mg/ml, designed specifically for intravenous administration. The recommended dose and schedule are determined by the treating physician based on individual health requirements. Strict adherence to prescribed guidelines ensures maximum patient benefit and minimizes risk.

FAQs of Edaravone Injection:

Q: How is Edaravone Injection administered to patients?

A: Edaravone Injection is given intravenously by a healthcare professional, ensuring the medication is delivered directly into the bloodstream for effective treatment of ALS.

Q: What is the main therapeutic benefit of using Edaravone Injection?

A: This injection provides neuroprotective effects that help slow the progression of amyotrophic lateral sclerosis (ALS) in adult patients.

Q: When should Edaravone Injection be used, and who qualifies for it?

A: Edaravone Injection is recommended for adult patients diagnosed with ALS and should be administered as prescribed by a physician following comprehensive medical evaluation.

Q: Where should Edaravone Injection be stored to preserve its quality?

A: It should be stored in a cool environment as per storage instructions to maintain its stability and efficacy throughout the 24-month shelf life.

Q: What is the process for receiving Edaravone Injection?

A: Patients receive this injection at healthcare facilities under supervision, as a physician determines the appropriate dose and administration schedule for their condition.

Q: What should patients consider before using Edaravone Injection?

A: Patients should consult their healthcare provider for tailored advice regarding dosage, suitability, and possible side effects to ensure safe and effective use.

Tell us about your requirement